Literature DB >> 25192797

Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating Sirt1 to resist AGEs-induced upregulation of fibronetin and transforming growth factor-β1 in rat glomerular messangial cells.

Kaipeng Huang1, Cheng Chen2, Jie Hao2, Junying Huang2, Shaogui Wang2, Peiqing Liu2, Heqing Huang3.   

Abstract

Sirt1 and nuclear factor-E2 related factor 2 (Nrf2)-anti-oxidant response element (ARE) anti-oxidative pathway play important regulatory roles in the pathological progression of diabetic nephropathy (DN) induced by advanced glycation-end products (AGEs). Polydatin (PD), a glucoside of resveratrol, has been shown to possess strong anti-oxidative bioactivity. Our previous study demonstrated that PD markedly resists the progression of diabetic renal fibrosis and thus, inhibits the development of DN. Whereas, whether PD could resist DN through regulating Sirt1 and consequently promoting Nrf2-ARE pathway needs further investigation. Here, we found that concomitant with decreasing RAGE (the specific receptor for AGEs) expression, PD significantly reversed the downregulation of Sirt1 in terms of protein expression and deacetylase activity and attenuated FN and TGF-β1 expression in GMCs exposed to AGEs. Under AGEs-treatment condition, PD could decrease Keap1 expression and promote the nuclear content, ARE-binding ability, and transcriptional activity of Nrf2. In addition, PD increased the protein levels of heme oxygenase 1 (HO-1) and superoxide dismutase 1 (SOD1), two target genes of Nrf2. The activation of Nrf2-ARE pathway by PD eventually led to the quenching of ROS overproduction sharply boosted by AGEs. Depletion of Sirt1 blocked Nrf2-ARE pathway activation and reversed FN and TGF-β1 downregulation induced by PD in GMCs challenged with AGEs. Along with reducing HO-1 and SOD1 expression, silencing of Nrf2 increased FN and TGF-β1 levels. PD treatment elevated Sirt1 and Nrf2 levels in the kidney tissues of diabetic rats, then improved the anti-oxidative capacity and renal dysfunction of diabetic models, and finally reversed the upregulation of FN and TGF-β1. Taken together, the resistance of PD on upregulated FN and TGF-β1 induced by AGEs via oxidative stress in GMCs is closely associated with its activation of Sirt1-Nrf2-ARE pathway.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Advanced glycation-end products; Diabetic nephropathy; Nrf2-ARE pathway; Oxidative stress; Polydatin; Sirt1

Mesh:

Substances:

Year:  2014        PMID: 25192797     DOI: 10.1016/j.mce.2014.08.014

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  49 in total

Review 1.  Relationships among alcoholic liver disease, antioxidants, and antioxidant enzymes.

Authors:  Kyu-Ho Han; Naoto Hashimoto; Michihiro Fukushima
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 2.  Natural antioxidants in the treatment and prevention of diabetic nephropathy; a potential approach that warrants clinical trials.

Authors:  Noori Al-Waili; Hamza Al-Waili; Thia Al-Waili; Khelod Salom
Journal:  Redox Rep       Date:  2017-03-09       Impact factor: 4.412

3.  Rice bran protein hydrolysates attenuate diabetic nephropathy in diabetic animal model.

Authors:  Kampeebhorn Boonloh; Eun Soo Lee; Hong Min Kim; Mi Hye Kwon; You Mi Kim; Patchareewan Pannangpetch; Bunkerd Kongyingyoes; Upa Kukongviriyapan; Supawan Thawornchinsombut; Eun Young Lee; Veerapol Kukongviriyapan; Choon Hee Chung
Journal:  Eur J Nutr       Date:  2016-12-21       Impact factor: 5.614

4.  Study of Insulin-Loaded Chitosan Nanoparticle Effects on TGF-β1 and Fibronectin Expression in Kidney Tissue of Type 1 Diabetic Rats.

Authors:  Azar Ghavimishamekh; Nasrin Ziamajidi; Arash Dehghan; Mohammad Taghi Goodarzi; Roghayeh Abbasalipourkabir
Journal:  Indian J Clin Biochem       Date:  2018-06-26

5.  SIRT1 Activation by Polydatin Alleviates Oxidative Damage and Elevates Mitochondrial Biogenesis in Experimental Diabetic Neuropathy.

Authors:  Preethi Bheereddy; Veera Ganesh Yerra; Anil Kumar Kalvala; Bhoomika Sherkhane; Ashutosh Kumar
Journal:  Cell Mol Neurobiol       Date:  2020-07-18       Impact factor: 5.046

Review 6.  SIRT1-SIRT7 in Diabetic Kidney Disease: Biological Functions and Molecular Mechanisms.

Authors:  Wenxiu Qi; Cheng Hu; Daqing Zhao; Xiangyan Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-13       Impact factor: 6.055

Review 7.  Pharmacological Approaches to Decelerate Aging: A Promising Path.

Authors:  Bahareh Hassani; Ghazal Goshtasbi; Shirin Nooraddini; Negar Firouzabadi
Journal:  Oxid Med Cell Longev       Date:  2022-07-11       Impact factor: 7.310

Review 8.  Activators of SIRT1 in the kidney and protective effects of SIRT1 during acute kidney injury (AKI) (effect of SIRT1 activators on acute kidney injury).

Authors:  Alireza Raji-Amirhasani; Mohammad Khaksari; Fatemeh Darvishzadeh Mahani; Zahra Hajializadeh
Journal:  Clin Exp Nephrol       Date:  2021-03-29       Impact factor: 2.801

Review 9.  Targeting mitochondrial dysfunction with small molecules in intervertebral disc aging and degeneration.

Authors:  Morteza Saberi; Xiaolei Zhang; Ali Mobasheri
Journal:  Geroscience       Date:  2021-02-26       Impact factor: 7.713

10.  Sirt1 and Nrf2: regulation of Leydig cell oxidant/antioxidant intracellular environment and steroid formation†.

Authors:  Jin-Yong Chung; Haolin Chen; Barry Zirkin
Journal:  Biol Reprod       Date:  2021-11-15       Impact factor: 4.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.